90 FR 12 pgs. 7173-7174 - Bulk Manufacturer of Controlled Substances Application: Invizyne Technologies, Inc.
Type: NOTICEVolume: 90Number: 12Pages: 7173 - 7174
Pages: 7173, 7174Docket number: [Docket No. DEA-1474]
FR document: [FR Doc. 2025-01347 Filed 1-17-25; 8:45 am]
Agency: Justice Department
Sub Agency: Drug Enforcement Administration
Official PDF Version: PDF Version
[top]
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA-1474]
Bulk Manufacturer of Controlled Substances Application: Invizyne Technologies, Inc.
AGENCY:
Drug Enforcement Administration, Justice.
ACTION:
Notice of application.
SUMMARY:
Invizyne Technologies, Inc. has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.
DATES:
Registered bulk manufacturers of the affected basic class(es), and applicants, therefore, may submit electronic comments on or objections to the issuance of the proposed registration on or before March 24, 2025. Such persons may also file a written request for a hearing on the application on or before March 24, 2025.
ADDRESSES:
[top] The Drug Enforcement Administration requires that all comments be submitted electronically through the Federal eRulemaking Portal, which provides the ability to type short comments directly into the comment field on the web page or attach a file for lengthier comments. Please go to https://www.regulations.gov and follow the online instructions at that site for submitting comments. Upon submission of your comment, you will receive a Comment Tracking Number. Please be
SUPPLEMENTARY INFORMATION:
In accordance with 21 CFR 1301.33(a), this is notice that on November 14, 2024, Invizyne Technologies, Inc., 750 Royal Oaks Drive, Suite 106, Monrovia, California 91016-6357 applied to be registered as a bulk manufacturer of the following basic class(es) of controlled substance(s):
| Controlled substance | Drug code | Schedule |
|---|---|---|
| Tetrahydrocannabinols | 7370 | I |
The company plans to bulk manufacture the listed controlled substance for the internal use intermediates or for sale to its customers. In reference to drug code 7370 (Tetrahydrocannabinols), the company plans to bulk manufacture this drug as synthetic. No other activity for this drug code is authorized for this registration.
Matthew Strait,
Deputy Assistant Administrator.
[FR Doc. 2025-01347 Filed 1-17-25; 8:45 am]
BILLING CODE P